Research Analysts Set Expectations for STOK FY2025 Earnings
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Cantor Fitzgerald decreased their FY2025 EPS estimates for shares of Stoke Therapeutics in a research note issued to investors on Thursday, June 12th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will earn ($0.34) per share for the year, down from their previous estimate of […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Cantor Fitzgerald decreased their FY2025 EPS estimates for shares of Stoke Therapeutics in a research note issued to investors on Thursday, June 12th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will earn ($0.34) per share for the year, down from their previous estimate of […]
